| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2023―Dec―12 |
Blood pressure control in tertiary-care hypertensive patients during COVID-19 pandemic |
Jacek Wolf, Anna Nieckarz, Anna Panfil, Aleksandra Białas, Julia Sternicka, Łukasz Jędrzejewski, Michał Hoffmann, Anna Szyndler, Aleksander Prejbisz, Michel Burnier, Krzysztof Narkiewicz |
| 2 |
[GO] |
2022―Sep―26 |
COVID-19 clinical outcomes in patients with and without ongoing therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers |
Ahmed Nafakhi, Ihsan Rabeea, Rasha AL-Darraji, Hussein Nafakhi, Ahmed Mechi, Alhan Al-khalidi |
| 3 |
[GO] |
2022―Sep―26 |
Why not change the therapy of hypertension in patients with COVID-19. Dual role of angiotensin-converting enzyme 2 |
Jerzy Głuszek, Teresa Kosicka |
| 4 |
[GO] |
2021―Dec―02 |
Hypertension management in the COVID-19 era. Getaway from pandemic snares |
Jacek Wolf, Krzysztof Narkiewicz |
| 5 |
[GO] |
2021―Dec―02 |
ACE gene I/D polymorphism and severity of SARS-CoV-2 infection in hospitalized patients: a meta-analysis |
Teodoro J. Oscanoa, Xavier Vidal, Eliecer Coto, Roman Romero-Ortuno |
| 6 |
[GO] |
2021―May―10 |
Blood parameters, symptoms at presentation and adverse in-hospital outcomes of COVID-19 pneumonia in patients with hypertension |
Foaad Shaghee, Hussein Nafakhi, Karrar Al-Buthabhak, Mohammed Alareedh, Ahmed Nafakhi, Samet Kasim |
| 7 |
[GO] |
2020―Dec―28 |
Severity of SARS-COV-2 infection and angiotensin converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis |
Teodoro J. Oscanoa, Xavier Vidal, Alfonso Carvajal, José Amado, Roman Romero-Ortuno |
| 8 |
[GO] |
2020―Dec―28 |
Treatment of overweight and obesity during and after a pandemic. Let’s not wait for the development of complications - new guidelines for doctors |
Magdalena Olszanecka-Glinianowicz, Dominika Dudek, Krzysztof J. Filipiak, Marek Krzystanek, Leszek Markuszewski, Marek Ruchała, Elżbieta Tomiak |
